Pamela B. Greene quoted on Regulation A+ in The Boston Globe

Our partner Pamela B. Greene was recently quoted in a Boston Globe article focusing on a local company’s use of Regulation A+ (or “Reg A+”) as a new way to raise capital, and the benefits and risks that may be associated with this kind of offering. The rules allowing Regulation A+ were adopted by the SEC in March 2015, as mandated by the Jumpstart Our Business Startups (JOBS) Act, and are designed to facilitate smaller companies’ access to capital. The rules enable smaller companies to offer and sell up to $50 million of securities in a 12-month period, subject to eligibility, disclosure and reporting requirements. A Cambridge, MA medical robotics company called Myomo is planning to complete an offering using this method. The article in which Pam is quoted can be found here.

Megan Gates is Co-chair of Mintz Levin’s Securities & Capital Markets Practice. She counsels public companies on compliance and disclosure obligations, public and private financing matters, and merger and acquisition transactions, and advises clients on corporate governance matters such as Sarbanes-Oxley compliance. Megan is frequently invited to speak at industry conferences on topics including securities offerings, corporate governance, and compliance matters.

Mintz Levin’s Securities Practice

High-stakes securities litigation demands the attention of sophisticated counsel experienced with civil and criminal proceedings, internal investigations, and SEC and other federal and state regulatory actions. Our Securities Litigation Practice has an extraordinary record of success representing clients in securities class actions, derivative suits, litigation, and SEC or other regulatory investigations and enforcement proceedings. In addition, Mintz Levin’s Securities & Capital Markets Practice represents issuers, underwriters, and investors in the full range of sophisticated securities transactions, from private placements and venture capital investments to initial and follow-on public offerings of equity, debt, and other securities, including registered direct offerings, PIPEs and confidentially marketed public offerings, and reverse mergers and other “alternative” means of accessing capital.Read More